Back
Checkpoint Therapeutics 10K Form
Sell
39
CKPT
Checkpoint Therapeutics
Last Price:
3.46
Seasonality Move:
-5.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CKPT News And Ratings
See the #1 stock for the next 7 days that we like better than CKPT
CKPT Financial Statistics
Sales & Book Value
| Annual Sales: | $103K |
|---|---|
| Cash Flow: | $-6.24M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.37 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.90000 |
|---|---|
| Net Income (TTM): | $-42.47M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | -632.35% |
Checkpoint Therapeutics Earnings Forecast
Key Checkpoint Therapeutics Financial Ratios
- The Research & Development expenses have been 42,297.09% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of CKPT is -50,336.89% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Checkpoint Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CKPT |
| CUSIP: | 162828 |
| Website: | checkpointtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.26 |
| Quick Ratio: | 0.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CKPT Technical Analysis vs Fundamental Analysis
Sell
39
Checkpoint Therapeutics (CKPT)
is a Sell
Is Checkpoint Therapeutics a Buy or a Sell?
-
Checkpoint Therapeutics stock is rated a Sell
The current Checkpoint Therapeutics [CKPT] share price is $3.37. The Score for CKPT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.